WMSA
AVNR

Weiss Multi-Strategy Advisers’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-100,000
Closed -$336K – 1243
2013
Q4 		$336K Buy
+100,000
New +$413K 0.01% 765

Other funds holding AVNR

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AVNR Position: Q4 2014 in Review

Weiss Multi-Strategy Advisers sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2014, closing a stake of 175,000 shares — an estimated $2.09M sold.

Weiss Multi-Strategy Advisers first reported a position in AVNR in Q2 2013 and held it in 6 quarters. The position peaked at $2.94M in Q2 2013. 166 funds tracked by Wall St. Rank hold AVNR as of Q4 2014.

  • Weiss Multi-Strategy Advisers reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q4 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 175,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q4 2014, an estimated $2.09M.
  • Weiss Multi-Strategy Advisers first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 6 quarters.
  • Weiss Multi-Strategy Advisers's AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.94M in Q2 2013.
  • 166 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2014, filed 17 Feb 2015.